Belimumab in Lupus Nephritis

被引：1

作者：

Rojas-Rivera, Jorge ^{[1
]}

Ortiz, Alberto ^{[1
]}

Carriazo, Sol ^{[1
]}

机构：

[1] Hosp Univ Fdn Jimenez Diaz, Madrid, Spain

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2021年 / 384卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

To the Editor: Furie et al. (Sept. 17 issue)(1) report the results of the Belimumab International Study in Lupus Nephritis (BLISS-LN), a large, randomized trial of intravenous belimumab as compared with placebo when added to standard therapy (mycophenolate mofetil or cyclophosphamide-azathioprine) in adults with active lupus nephritis. There was adequate follow-up time, but several points need clarification. Notably, one third of the patients were not taking a renin-angiotensin system (RAS) blocker at baseline. Although initiation of an RAS blockade was encouraged, it would have to have been initiated before week 24; treatment would otherwise be considered to have failed. Since . . .

引用

页码：187 / 187

页数：1

共 50 条

[31] Treatment Using Both Voclosporin and Belimumab in Four Patients With Lupus Nephritis
Baum, Rebecca
Geetha, Duruvu
Fatola, Ayotola
Timlin, Homa
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
[32] Effectiveness of Belimumab for Glucocorticoid Discontinuation in Juvenile-Onset Lupus Nephritis
Kise, Tomoo
Uehara, Masatsugu
INDIAN JOURNAL OF NEPHROLOGY, 2025, 35 (01) : 85 - 87
[33] Efficacy of belimumab monotherapy in high infectious risk patient affected by lupus nephritis
D'Alessandro, Roberto
Gonzalez, Estrella Garcia
Frediani, Bruno
RHEUMATOLOGY ADVANCES IN PRACTICE, 2021, 5 (01)
[34] Treatment of Lupus Nephritis with Belimumab Is Associated with Reduction in Urinary CD23
Weeding, Emma
Fava, Andrea
Mohan, Chandra
Goldman, Daniel
Petri, Michelle
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3617 - 3619
[35] Thrombotic microangiopathy with refractory lupus nephritis successfully treated by combining rituximab with belimumab
Hanai, S.
Kobayashi, Y.
Ito, R.
Harama, K.
Nakagomi, D.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2023, 52 (02) : 227 - 229
[36] Biological sequential therapy with rituximab-belimumab in patients with recurrent lupus nephritis
Robles-Marhuenda, Angel
Cobo-Ibanez, Tatiana
Noblejas-Mozo, Ana
Munoz-Fernandez, Santiago
REUMATOLOGIA CLINICA, 2023, 19 (05): : 290 - 291
[37] Efficacy and safety of belimumab combined with the standard regimen in treating children with lupus nephritis
Li, Huarong
Chen, Chaoying
Yang, Hongxian
Tu, Juan
EUROPEAN JOURNAL OF PEDIATRICS, 2024, 183 (09) : 3987 - 3995
[38] The Cost-Effectiveness of Belimumab and Voclosporin for Patients with Lupus Nephritis in the United States
Mandrik, Olena
Fotheringham, James
Ren, Shijie
Tice, Jeffrey A.
Chapman, Richard H.
Stevenson, Matthew D.
Pearson, Steven D.
Herron-Smith, Serina
Agboola, Foluso
Thokala, Praveen
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (03): : 385 - 394
[39] Extrapolation of the Efficacy and Pharmacokinetics of Belimumab to Support its Use in Children with Lupus Nephritis
Dimelow, Richard
Liefaard, Lia
Green, Yulia
Tomlinson, Ryan
CLINICAL PHARMACOKINETICS, 2024, 63 (09) : 1313 - 1326
[40] Effect of belimumab in renal function and proteinuria in patients with lupus nephritis (LN): our experience
Liebana, Marc Patricio
Romeo, Maria Jose Soler
Hernandez, Josefina Cortes
Gabaldon, Maria Alejandra
Carrillo, Jorge Ivan Zamora
Lopez, Marina
Borda, Jhusel Rosas
Garcia, Sheila Bermejo
Berna, Gerson
Leon, Juan Carlos
Matamoros, Oriol Bestard
Pamplona, Irene Agraz
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39

← 1 2 3 4 5 →